The European Union rejected Brazil’s proposal to gradually implement new health requirements related to the use of antimicrobials in animal production.
Thus, from September 3, Brazilian exporters must fully comply with the new rules to maintain access to the European market.
European regulations prohibit the use of antimicrobials as growth promoters or to increase productivity, and also restrict substances considered critical to human health. In May, the EU removed Brazil from the list of countries authorized to export animal products to the bloc due to non-compliance with these regulations.
The Brazilian government had proposed a two-stage transition. Initially, slaughterhouses had to demonstrate that cattle had not received prohibited medications in the nine months prior to slaughter, while comprehensive traceability throughout the animal’s life would only be implemented around 2029.
However, Brussels ruled out any easing of restrictions. According to sources involved in the negotiations, the decision was already considered likely within the Brazilian government.
The potential impact on Brazilian exports could reach up to US$2 billion, according to official estimates. The main challenge for the supply chain will be ensuring traceability and auditable documentation regarding drug use, animal origin, batch identification, and sanitary compliance.
Exporters and meatpacking plants have already begun reviewing contracts and compliance protocols, incorporating greater control and audit requirements for suppliers.
The concern is especially high among small and medium-sized producers, who could face greater difficulties in adapting to the new European requirements.
